Tyra Biosciences, Inc. (TYRA)
20.39
+0.15
(+0.74%)
USD |
NASDAQ |
Oct 07, 16:00
20.39
0.00 (0.00%)
After-Hours: 20:00
Tyra Biosciences Max Drawdown (5Y) : 83.22% for Sept. 30, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| September 30, 2026 | 83.22% |
| August 31, 2026 | 83.22% |
| July 31, 2026 | 83.22% |
| June 30, 2026 | 83.22% |
| May 31, 2026 | 83.22% |
| April 30, 2026 | 83.22% |
| Date | Value |
|---|---|
| March 31, 2026 | 83.22% |
| February 28, 2026 | 83.22% |
| January 31, 2026 | 83.22% |
| December 31, 2025 | 83.22% |
| November 30, 2025 | 83.22% |
| October 31, 2025 | 83.22% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 88.96% |
| Oncolytics Biotech, Inc. | 92.83% |
| Sangamo Therapeutics, Inc. | 99.68% |
| Sarepta Therapeutics, Inc. | 93.33% |
| Anixa Biosciences, Inc. | 70.17% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -6.855 |
| Beta (5Y) | 0.7518 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 78.73% |
| Historical Sharpe Ratio (5Y) | 0.0085 |
| Historical Sortino (5Y) | 0.018 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 28.44% |